Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Cash from Operations (2016 - 2026)

Cartesian Therapeutics (RNAC) has disclosed Cash from Operations for 12 consecutive years, with 22135000.0 as the latest value for Q1 2026.

  • For Q1 2026, Cash from Operations rose 4.21% year-over-year to 22135000.0; the TTM value through Mar 2026 reached 72968000.0, down 136.41%, while the annual FY2025 figure was 73941000.0, 212.33% down from the prior year.
  • Cash from Operations hit 22135000.0 in Q1 2026 for Cartesian Therapeutics, down from 17712000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 13691000.0 in Q3 2024 and bottomed at 23286000.0 in Q4 2023.
  • Average Cash from Operations over 5 years is 11914235.29, with a median of 12271000.0 recorded in 2022.
  • Year-over-year, Cash from Operations plummeted 311.69% in 2023 and then soared 248.57% in 2024.
  • Cartesian Therapeutics' Cash from Operations stood at 11849000.0 in 2022, then plummeted by 96.52% to 23286000.0 in 2023, then surged by 69.93% to 7002000.0 in 2024, then tumbled by 152.96% to 17712000.0 in 2025, then decreased by 24.97% to 22135000.0 in 2026.
  • According to Business Quant data, Cash from Operations over the past three periods came in at 22135000.0, 17712000.0, and 15600000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.